Tag Archives | pharmaceutical systems

What Gets Defined, Gets Measured: A Definition and Framework for Pharmaceutical Systems Strengthening

A presentation by Helena Walkowiak, Principal Technical Advisor for SIAPS, on December 6 2017.

Read full story · Comments are closed

Pharmaceutical management considerations for expanded coverage of essential health services and financial protection programs

The UN adoption of the SDGs in 2015 signaled a strong commitment of member countries to the expanded access to essential health service agenda and definitively recognized the critical role of medicines in achieving UHC. The SDGs call for countries to “achieve universal health coverage, including financial risk protection, access to quality essential health care services and access to safe, effective, quality and affordable essential medicines and vaccines for all”. This paper seeks to highlight the key functional areas of pharmaceutical management, the critical components of the pharmaceutical system, and the management considerations needed to facilitate the attainment of UHC targets.

Read full story · Comments are closed

Special preview: A new tool to measure pharmaceutical systems strengthening

By Helena Walkowiak and Maura Soucy Brown In SIAPS’ upcoming webinar on defining and measuring pharmaceutical systems strengthening (PSS), we’ll talk briefly about the development of a new tool that SIAPS and its partners are piloting. It’s intended to help the field measure the impact of PSS efforts. Some background on this activity: SIAPS has […]

Read full story · Comments { 0 }

What Gets Defined, Gets Measured: Definitions and a Framework for Measuring Pharmaceutical Systems Strengthening

SIAPS is presenting its webinar “What Gets Defined, Gets Measured: Definitions and a Framework for Measuring Pharmaceutical Systems Strengthening” on Wednesday, December 6, at 8:00 am EST. Although a variety of tools are available to measure different elements of pharmaceutical systems, few attempts have been made to conceptualize a “pharmaceutical system” as an entity and […]

Read full story · Comments { 0 }

Leadership Development Program Training to Strengthen Pharmaceutical Management in Sierra Leone

In May 2017, SIAPS held a Leadership Development Program (LDP) training to build the capacity of the Directorate of Drugs and Medical Supplies (DDMS), district and hospital pharmacists, and SIAPS field staff. It was the first such training in the country.  The program aims to train pharmacists on basic principles and practices of good leadership, management, and governance to help them identify challenges like system and budget constraints—and to lead their teams in handling them with maximum efficiency, collaboration, and transparency. Another training goal is to help pharmaceutical managers optimize the SIAPS-supported Continuous Results Monitoring and Support System (CRMS), which has been implemented nationwide. The training created a pool of local LDP facilitators who can extend their knowledge to other DDMS staff and to pharmacists throughout all 13 districts in Sierra Leone.

Read full story · Comments are closed

To measure progress in “pharmaceutical systems strengthening,” we must first define that term

By Helena Walkowiak, Principal Technical Advisor, SIAPS It’s been called the pharmaceutical sector, a drug supply or management system or the medical products building block. By any name, the part of a health system that deals with ensuring access to essential medicines, vaccines and medical products and their correct use–we call it a pharmaceutical system […]

Read full story · Comments { 0 }

The Organization of an Integrated Medicine and Supply Management System in the Dominican Republic: Progress and Challenges

In 2008, a rapid study of the status of medicine supply management in the Dominican Republic determined that one of the primary causes of supply inefficiencies and stock-outs was the fragmentation of the supply process into multiple vertical chains organized around disease control programs (DCPs), such as those addressing tuberculosis (TB) and HIV/AIDS. With support provided by technical and financial cooperation agencies, these DCPs relied on individual mechanisms for planning purchases, procurement, and storage, as well as requisition, delivery, and information systems for managing the supply process. Although the 2008 study did not establish the cost of these supply chains, it was apparent that fragmentation had led to high costs and inefficiencies. For example, a number of different requisition forms were completed periodically by the same health facility personnel, resulting in the receipt of uncoordinated shipments from various suppliers.

The results of this study and a proposal for the organization of an integrated pharmaceutical system were presented to health authorities and technical cooperation agencies in 2008. Based on the evidence presented, the Ministry of Public Health asked the US Agency for International Development (USAID) for technical assistance from its pharmaceutical supply management partners in implementing what would subsequently be known as the Integrated System for Medicine and Supply Management (Sistema Único de Gestión de Medicamentos e Insumos; SUGEMI). In 2010, political will was officially backed up by the issuance of Ministerial Decree No. 00019-2010 to establish SUGEMI as the institutional mechanism for organizing the pharmaceutical supply system in the public network of health care facilities.

This report outlines the structure, functions, and challenges presented by the establishment of SUGEMI.

Read full story · Comments are closed